Valuation: Recordati

Market Cap 10.86B 12.15B 10.1B 9.18B 17.34B 1,176B 17.42B 122B 47.62B 600B 45.64B 44.64B 1,925B P/E 2026 *
21.5x
P/E 2027 * 17.5x
Enterprise Value 12.62B 14.13B 11.74B 10.68B 20.16B 1,368B 20.25B 141B 55.36B 697B 53.07B 51.91B 2,238B EV / Sales 2026 *
4.52x
EV / Sales 2027 * 4.06x
Free-Float
50.46%
Yield 2026 *
2.87%
Yield 2027 * 3.17%
1 week+0.76%
Current month+0.66%
1 month+1.92%
3 months+3.31%
6 months+8.83%
Current year+9.19%
1 week 52.2
Extreme 52.2
53.15
1 month 52
Extreme 52
53.2
Current year 43.76
Extreme 43.76
53.7
1 year 43.76
Extreme 43.76
54.45
3 years 43.04
Extreme 43.04
60.95
5 years 34.52
Extreme 34.52
60.95
10 years 24.55
Extreme 24.55
60.95
Manager TitleAgeSince
Chief Executive Officer 64 01/12/2021
Director of Finance/CFO 56 01/01/2026
Chief Tech/Sci/R&D Officer 56 01/10/2023
Director TitleAgeSince
Chairman 54 01/12/2021
Chairman 57 12/06/2018
Director/Board Member 53 12/06/2018
Date Insider Type Main position Quantity % Market Cap. Importance
11/12/25
Arisca SRL
BuyCompany 10,071 0.0048%
11/12/25 Buy

Chief Financial Officer

2,000 0.0010%
11/12/25 Buy

Chief Financial Officer

2,000 0.0010%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+0.76%+0.76%+18.73% 12.15B
+0.83%+3.19%+37.87%+106.25% 1,051B
+1.93%+2.11%+36.82%+64.90% 630B
+1.49%+5.19%+19.84%+85.41% 489B
+2.26%+0.90%+66.40%+39.33% 359B
+1.45%+3.50%+21.87%+42.64% 344B
+1.17%+2.37%+11.71%+35.14% 272B
+0.89%+1.08%-7.28%+10.52% 246B
+1.82%+2.94%+40.43%+52.78% 224B
+2.77%+4.44%+29.49%+101.40% 187B
Average +1.35%+2.44%+25.79%+55.71% 381.59B
Weighted average by Cap. +1.19%+2.50%+31.47%+69.80%

Financials

2026 *2027 *
Net sales 2.79B 3.13B 2.6B 2.36B 4.46B 303B 4.48B 31.26B 12.25B 154B 11.74B 11.48B 495B 3.03B 3.39B 2.82B 2.56B 4.84B 328B 4.86B 33.9B 13.28B 167B 12.73B 12.45B 537B
Net income 570M 638M 530M 483M 911M 61.79B 915M 6.38B 2.5B 31.5B 2.4B 2.35B 101B 684M 766M 636M 579M 1.09B 74.13B 1.1B 7.66B 3B 37.8B 2.88B 2.81B 121B
Net Debt 1.77B 1.98B 1.64B 1.49B 2.82B 191B 2.83B 19.77B 7.74B 97.54B 7.42B 7.26B 313B 1.45B 1.63B 1.35B 1.23B 2.32B 157B 2.33B 16.25B 6.37B 80.2B 6.1B 5.97B 257B
Projected Income Statement - Annual - Recordati
Logo Recordati
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows: - pharmaceutical and OTC products (58.7%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.; - medicines for rare diseases (41.3%). Net sales are distributed geographically as follows: Italy (12.6%), Europe (53.7%), America (23.1%), Asia and Oceania (7.8%) and Africa (2.8%).
Employees
4,654
Date Price Change Volume
09/10/26 €53.00 0.00% 232,728
08/10/26 €53.00 0.00% 341,012
07/10/26 €53.00 -0.19% 256,981
06/10/26 €53.10 +1.72% 732,869
05/10/26 €52.20 -0.76% 299,026
Trader
Investor
Global
Quality
ESG MSCI
A
Ratings Surperformance© - Recordati
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
53.00EUR
Average target price
60.10EUR
Spread / Average Target
+13.40%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Recordati